Daniel Wilson to Animals
This is a "connection" page, showing publications Daniel Wilson has written about Animals.
Connection Strength
0.197
-
Machine learning to predict the source of campylobacteriosis using whole genome data. PLoS Genet. 2021 10; 17(10):e1009436.
Score: 0.049
-
A population genetics-phylogenetics approach to inferring natural selection in coding sequences. PLoS Genet. 2011 Dec; 7(12):e1002395.
Score: 0.025
-
Tracing the source of campylobacteriosis. PLoS Genet. 2008 Sep 26; 4(9):e1000203.
Score: 0.020
-
Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis. Eur J Med Chem. 2020 Sep 01; 201:112408.
Score: 0.011
-
Combining genomics and epidemiology to analyse bi-directional transmission of Mycobacterium bovis in a multi-host system. Elife. 2019 12 17; 8.
Score: 0.011
-
5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors. J Med Chem. 2016 Apr 14; 59(7):2928-41.
Score: 0.008
-
Rapid host switching in generalist Campylobacter strains erodes the signal for tracing human infections. ISME J. 2016 Mar; 10(3):721-9.
Score: 0.008
-
Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach. J Med Chem. 2014 Oct 23; 57(20):8340-57.
Score: 0.008
-
Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase. Bioorg Med Chem. 2014 Mar 01; 22(5):1726-35.
Score: 0.007
-
A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence. Proc Natl Acad Sci U S A. 2013 Nov 19; 110(47):19095-100.
Score: 0.007
-
Evaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expression. PLoS Pathog. 2011 Sep; 7(9):e1002264.
Score: 0.006
-
Utilizing a combination of molecular and spatial tools to assess the effect of a public health intervention. Prev Vet Med. 2011 Dec 01; 102(3):242-53.
Score: 0.006
-
Evolution of an agriculture-associated disease causing Campylobacter coli clade: evidence from national surveillance data in Scotland. PLoS One. 2010 Dec 15; 5(12):e15708.
Score: 0.006
-
Molecular and spatial epidemiology of human campylobacteriosis: source association and genotype-related risk factors. Epidemiol Infect. 2010 Oct; 138(10):1372-83.
Score: 0.005
-
Assigning the source of human campylobacteriosis in New Zealand: a comparative genetic and epidemiological approach. Infect Genet Evol. 2009 Dec; 9(6):1311-9.
Score: 0.005
-
Campylobacter genotyping to determine the source of human infection. Clin Infect Dis. 2009 Apr 15; 48(8):1072-8.
Score: 0.005
-
Inhibition of siderophore biosynthesis by 2-triazole substituted analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: antibacterial nucleosides effective against Mycobacterium tuberculosis. J Med Chem. 2008 Dec 11; 51(23):7495-507.
Score: 0.005
-
Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine. J Med Chem. 2008 Sep 11; 51(17):5349-70.
Score: 0.005